Showing results (1701-1710 of 1,799) with videos related to
Sort By:
Pageof 180
Mabs|October 17, 2025
Modular generation of multispecific antibodies using protein trans-splicingJared A Shadish, John D Bagert, Amber N Lee, et al.Mabs|June 18, 2020
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemicKewen Qian, Shi HuMabs|June 17, 2020
Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffoldZehua Sun, Chuan Chen, Wei Li, et al.Mabs|September 17, 2021
Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settingsEva Germovsek, Ming Cheng, Craig GiragossianMabs|October 22, 2019
Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometryChristoph Gstöttner, Dietmar Reusch, Markus Haberger, et al.Mabs|April 25, 2020
In vitro affinity optimization of an anti-BDNF monoclonal antibody translates to improved potency in targeting chronic pain states in vivoEdwina Stack, Sheridan McMurray, Gordon McMurray, et al.Mabs|April 21, 2020
Preclinical characterization of the ADME properties of a surrogate anti-IL-36R monoclonal antibody antagonist in mouse serum and tissuesKip P Conner, Cinthia V Pastuskovas, Marcus Soto, et al.Mabs|September 6, 2021
Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugateDifei Qiu, Yande Huang, Naresh Chennamsetty, et al.Mabs|September 24, 2025
A highly selective TCR-mimic antibody reveals unexpected mechanisms of HBV peptide-MHC recognition and previously unknown target biologyShahzada Khan, Jeremy Lum, Heather Stephenson, et al.Mabs|September 15, 2025
Mechanistic and predictive formulation development for viscosity mitigation of high-concentration biotherapeuticsMatthew A Cruz, Marco Blanco, Iriny EkladiousPageof 180